ID   SYNJ1_RAT               Reviewed;        1574 AA.
AC   Q62910; O89092; Q62911; Q810Z8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 3.
DT   02-OCT-2024, entry version 201.
DE   RecName: Full=Synaptojanin-1;
DE            EC=3.1.3.36 {ECO:0000269|PubMed:8552192};
DE   AltName: Full=Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1;
GN   Name=Synj1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4 AND 5), FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8552192; DOI=10.1038/379353a0;
RA   McPherson P.S., Garcia E.P., Slepnev V.I., David C., Zhang X., Grabs D.,
RA   Sossin W.S., Bauerfeind R., Nemoto Y., De Camilli P.;
RT   "A presynaptic inositol-5-phosphatase.";
RL   Nature 379:353-357(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), CATALYTIC ACTIVITY (ISOFORM 3),
RP   TISSUE SPECIFICITY (ISOFORM 3), AND DOMAIN (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9710239; DOI=10.1016/s0014-5793(98)00820-5;
RA   Woscholski R., Finan P.M., Radley E., Parker P.J.;
RT   "Identification and characterisation of a novel splice variant of
RT   synaptojanin1.";
RL   FEBS Lett. 432:5-8(1998).
RN   [3]
RP   ALTERNATIVE SPLICING, TISSUE SPECIFICITY (ISOFORMS 1 AND 2), DEVELOPMENTAL
RP   STAGE (ISOFORMS 1 AND 2), AND SUBCELLULAR LOCATION (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8798761; DOI=10.1074/jbc.271.40.24856;
RA   Ramjaun A.R., McPherson P.S.;
RT   "Tissue-specific alternative splicing generates two synaptojanin isoforms
RT   with differential membrane binding properties.";
RL   J. Biol. Chem. 271:24856-24861(1996).
RN   [4]
RP   FUNCTION, INTERACTION WITH EPS15, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=9428629; DOI=10.1016/s0014-5793(97)01451-8;
RA   Haffner C., Takei K., Chen H., Ringstad N., Hudson A., Butler M.H.,
RA   Salcini A.E., Di Fiore P.P., De Camilli P.;
RT   "Synaptojanin 1: localization on coated endocytic intermediates in nerve
RT   terminals and interaction of its 170 kDa isoform with Eps15.";
RL   FEBS Lett. 419:175-180(1997).
RN   [5]
RP   INTERACTION WITH SH3GL1; SH3GL2 AND SH3GL3, AND DOMAIN.
RC   TISSUE=Brain;
RX   PubMed=9238017; DOI=10.1073/pnas.94.16.8569;
RA   Ringstad N., Nemoto Y., De Camilli P.;
RT   "The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin
RT   and dynamin via a Grb2-like Src homology 3 domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:8569-8574(1997).
RN   [6]
RP   INTERACTION WITH SH3GL2; AMPH; DNM1 AND BIN1, AND DOMAIN.
RX   PubMed=9341169; DOI=10.1074/jbc.272.43.27239;
RA   Micheva K.D., Kay B.K., McPherson P.S.;
RT   "Synaptojanin forms two separate complexes in the nerve terminal.
RT   Interactions with endophilin and amphiphysin.";
RL   J. Biol. Chem. 272:27239-27245(1997).
RN   [7]
RP   INTERACTION WITH MYO1E.
RX   PubMed=17257598; DOI=10.1016/j.febslet.2007.01.021;
RA   Krendel M., Osterweil E.K., Mooseker M.S.;
RT   "Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in
RT   endocytosis.";
RL   FEBS Lett. 581:644-650(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-820; SER-1053; SER-1175;
RP   SER-1350 AND SER-1566, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Phosphatase that acts on various phosphoinositides, including
CC       phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-
CC       bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate
CC       (PubMed:8552192). Has a role in clathrin-mediated endocytosis
CC       (PubMed:9428629). Hydrolyzes PIP2 bound to actin regulatory proteins
CC       resulting in the rearrangement of actin filaments downstream of
CC       tyrosine kinase and ASH/GRB2 (By similarity).
CC       {ECO:0000250|UniProtKB:O18964, ECO:0000269|PubMed:8552192,
CC       ECO:0000269|PubMed:9428629}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol 4-phosphate) + phosphate; Xref=Rhea:RHEA:22764,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58178,
CC         ChEBI:CHEBI:58456; EC=3.1.3.36;
CC         Evidence={ECO:0000269|PubMed:8552192};
CC   -!- CATALYTIC ACTIVITY: [Isoform 3]:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol 4-phosphate) + phosphate; Xref=Rhea:RHEA:22764,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:58178,
CC         ChEBI:CHEBI:58456; EC=3.1.3.36;
CC         Evidence={ECO:0000269|PubMed:9710239};
CC   -!- SUBUNIT: Interacts with ASH/GRB2. Interacts with PACSIN1, PACSIN2 and
CC       PACSIN3 (By similarity). Interacts with AMPH, SH3GL1, SH3GL2 and SH3GL3
CC       (PubMed:9238017, PubMed:9341169). Interacts with MYO1E (via SH3 domain)
CC       (PubMed:17257598). Interacts with BIN1 and DNM1 (PubMed:9341169).
CC       Interacts with EPS15 (PubMed:9428629). {ECO:0000250|UniProtKB:O18964,
CC       ECO:0000250|UniProtKB:Q8CHC4, ECO:0000269|PubMed:17257598,
CC       ECO:0000269|PubMed:9238017, ECO:0000269|PubMed:9341169,
CC       ECO:0000269|PubMed:9428629}.
CC   -!- INTERACTION:
CC       Q62910; O35179: Sh3gl2; NbExp=2; IntAct=EBI-1149123, EBI-1149197;
CC       Q62910; O35180: Sh3gl3; NbExp=2; IntAct=EBI-1149123, EBI-1149266;
CC       Q62910; Q12965: MYO1E; Xeno; NbExp=2; IntAct=EBI-1149123, EBI-4279548;
CC       Q62910; Q99962: SH3GL2; Xeno; NbExp=2; IntAct=EBI-1149123, EBI-77938;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Membrane
CC       {ECO:0000269|PubMed:8798761}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:O18964}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=A stop codon is created in position 1309 of isoform 1 due to
CC         alternative splicing. {ECO:0000269|PubMed:8798761};
CC       Name=1; Synonyms=170 kDa;
CC         IsoId=Q62910-1; Sequence=Displayed;
CC       Name=2; Synonyms=145 kDa;
CC         IsoId=Q62910-2; Sequence=VSP_002686;
CC       Name=3; Synonyms=Delta-SAC;
CC         IsoId=Q62910-3; Sequence=VSP_002684;
CC       Name=4; Synonyms=170 kDa-16AA;
CC         IsoId=Q62910-4; Sequence=VSP_002685;
CC       Name=5; Synonyms=145 kDa-16AA;
CC         IsoId=Q62910-5; Sequence=VSP_002685, VSP_002686;
CC       Name=6; Synonyms=Delta-SAC-16AA;
CC         IsoId=Q62910-6; Sequence=VSP_002684, VSP_002685;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Found in neonatal brain, and in a wide
CC       variety of adult non-neuronal tissues. Concentrated at clathrin-coated
CC       endocytic intermediates in nerve terminals. Also detected in the lung
CC       and heart. Expressed at higher levels than isoform 2 in the testis and
CC       liver and is not detected in the skeletal muscle.
CC       {ECO:0000269|PubMed:8798761, ECO:0000269|PubMed:9428629}.
CC   -!- TISSUE SPECIFICITY: [Isoform 2]: Expressed predominantly in the
CC       neurons, but is also found in all other tissues at much lower levels.
CC       Also detected in the lung and heart. Epressed at lower levels than
CC       isoform 1 in the testis and liver and is not detected in the skeletal
CC       muscle. {ECO:0000269|PubMed:8798761}.
CC   -!- TISSUE SPECIFICITY: [Isoform 3]: Expressed in the brain.
CC       {ECO:0000269|PubMed:9710239}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 1]: Expression seen at 12 dpc, 16 dpc and
CC       18 dpc. In the adult brain expression decreases to undetectable levels.
CC       {ECO:0000269|PubMed:8798761}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 2]: Expression seen at 16 dpc and 18 dpc.
CC       In the adult brain expression increases dramatically as compared with
CC       its expression in embryonic brain. {ECO:0000269|PubMed:8798761}.
CC   -!- DOMAIN: Interacts with EPS15 (a clathrin coat-associated protein) via a
CC       C-terminal domain containing three Asn-Pro-Phe (NPF) repeats.
CC       {ECO:0000269|PubMed:9428629}.
CC   -!- DOMAIN: The C-terminal proline-rich region mediates binding to a
CC       variety of SH3 domain-containing proteins including AMPH, SH3GL1,
CC       SH3GL2 and SH3GL3. {ECO:0000269|PubMed:9238017,
CC       ECO:0000269|PubMed:9341169}.
CC   -!- DOMAIN: [Isoform 3]: Absence of SAC1 domain due to splicing does not
CC       alter its catalytic activity. {ECO:0000269|PubMed:9710239}.
CC   -!- SIMILARITY: Belongs to the synaptojanin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the inositol 1,4,5-
CC       trisphosphate 5-phosphatase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U45479; AAB60525.2; -; mRNA.
DR   EMBL; U91836; AAO24807.1; -; mRNA.
DR   EMBL; AJ006855; CAA07267.1; ALT_TERM; mRNA.
DR   PIR; S68448; S68448.
DR   RefSeq; NP_445928.2; NM_053476.2.
DR   AlphaFoldDB; Q62910; -.
DR   SMR; Q62910; -.
DR   BioGRID; 250042; 21.
DR   CORUM; Q62910; -.
DR   ELM; Q62910; -.
DR   IntAct; Q62910; 15.
DR   MINT; Q62910; -.
DR   STRING; 10116.ENSRNOP00000060346; -.
DR   GlyGen; Q62910; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62910; -.
DR   PhosphoSitePlus; Q62910; -.
DR   jPOST; Q62910; -.
DR   PaxDb; 10116-ENSRNOP00000045019; -.
DR   Ensembl; ENSRNOT00000052033.7; ENSRNOP00000045019.6; ENSRNOG00000002051.9. [Q62910-2]
DR   GeneID; 85238; -.
DR   KEGG; rno:85238; -.
DR   UCSC; RGD:69434; rat. [Q62910-1]
DR   AGR; RGD:69434; -.
DR   CTD; 8867; -.
DR   RGD; 69434; Synj1.
DR   VEuPathDB; HostDB:ENSRNOG00000002051; -.
DR   eggNOG; KOG0566; Eukaryota.
DR   GeneTree; ENSGT00940000157964; -.
DR   InParanoid; Q62910; -.
DR   OrthoDB; 21647at2759; -.
DR   PhylomeDB; Q62910; -.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   Reactome; R-RNO-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   PRO; PR:Q62910; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000002051; Expressed in Ammon's horn and 19 other cell types or tissues.
DR   ExpressionAtlas; Q62910; baseline and differential.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0030117; C:membrane coat; ISO:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043195; C:terminal bouton; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0012506; C:vesicle membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1990175; F:EH domain binding; IDA:RGD.
DR   GO; GO:0052658; F:inositol-1,4,5-trisphosphate 5-phosphatase activity; IDA:RGD.
DR   GO; GO:0034595; F:phosphatidylinositol phosphate 5-phosphatase activity; IDA:RGD.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphate phosphatase activity; ISO:RGD.
DR   GO; GO:0004439; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0043812; F:phosphatidylinositol-4-phosphate phosphatase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; ISO:RGD.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISO:RGD.
DR   GO; GO:1904980; P:positive regulation of endosome organization; ISO:RGD.
DR   GO; GO:0014015; P:positive regulation of gliogenesis; IMP:RGD.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IMP:RGD.
DR   GO; GO:0098884; P:postsynaptic neurotransmitter receptor internalization; ISO:RGD.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; ISO:RGD.
DR   GO; GO:0034097; P:response to cytokine; IMP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IMP:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0016082; P:synaptic vesicle priming; ISO:RGD.
DR   GO; GO:0048489; P:synaptic vesicle transport; ISO:RGD.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; ISO:RGD.
DR   CDD; cd09098; INPP5c_Synj1; 1.
DR   CDD; cd12719; RRM_SYNJ1; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 3.60.10.10; Endonuclease/exonuclease/phosphatase; 1.
DR   InterPro; IPR036691; Endo/exonu/phosph_ase_sf.
DR   InterPro; IPR046985; IP5.
DR   InterPro; IPR000300; IPPc.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR002013; SAC_dom.
DR   InterPro; IPR015047; SYNJ1/2_RRM.
DR   InterPro; IPR034971; SYNJ1_RRM.
DR   PANTHER; PTHR11200; INOSITOL 5-PHOSPHATASE; 1.
DR   PANTHER; PTHR11200:SF158; SYNAPTOJANIN-1; 1.
DR   Pfam; PF08952; DUF1866; 1.
DR   Pfam; PF22669; Exo_endo_phos2; 1.
DR   Pfam; PF02383; Syja_N; 1.
DR   SMART; SM01165; DUF1866; 1.
DR   SMART; SM00128; IPPc; 1.
DR   SUPFAM; SSF56219; DNase I-like; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50275; SAC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Endocytosis; Hydrolase; Lipid metabolism;
KW   Membrane; Methylation; Phosphoprotein; Reference proteome; Repeat;
KW   RNA-binding.
FT   CHAIN           1..1574
FT                   /note="Synaptojanin-1"
FT                   /id="PRO_0000209732"
FT   DOMAIN          119..442
FT                   /note="SAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00183"
FT   DOMAIN          894..971
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REPEAT          1401..1403
FT                   /note="1"
FT   REPEAT          1410..1412
FT                   /note="2"
FT   REPEAT          1421..1423
FT                   /note="3"
FT   REGION          500..899
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000255"
FT   REGION          1029..1327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1382..1519
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1401..1423
FT                   /note="3 X 3 AA repeats of N-P-F"
FT                   /evidence="ECO:0000269|PubMed:9428629"
FT   REGION          1532..1574
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1029..1059
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1074..1100
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1101..1131
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1205..1227
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1238..1253
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1263..1288
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1289..1314
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1382..1441
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1456..1485
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1487..1501
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1505..1519
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1533..1550
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1551..1574
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         820
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         830
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43426"
FT   MOD_RES         1053
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CHC4"
FT   MOD_RES         1175
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1198
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CHC4"
FT   MOD_RES         1217
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43426"
FT   MOD_RES         1289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43426"
FT   MOD_RES         1350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1354
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CHC4"
FT   MOD_RES         1566
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         1..400
FT                   /note="Missing (in isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:9710239"
FT                   /id="VSP_002684"
FT   VAR_SEQ         1141..1156
FT                   /note="Missing (in isoform 4, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:8552192"
FT                   /id="VSP_002685"
FT   VAR_SEQ         1309..1574
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:8552192"
FT                   /id="VSP_002686"
SQ   SEQUENCE   1574 AA;  172881 MW;  F24B90CE48F55508 CRC64;
     MAFSKGFRIY HKLDPPPFSL IVETRHKEEC LMFESGAVAV LSSAEKEAIK GTYAKVLDAY
     GLLGVLRLNL GDTMLHYLVL VTGCMSVGKI QESEVFRVTS TEFISLRVDA SDEDRISEVR
     KVLNSGNFYF AWSASGVSLD LSLNAHRSMQ EHTTDNRFFW NQSLHLHLKH YGVNCDDWLL
     RLMCGGVEIR TIYAAHKQAK ACLISRLSCE RAGTRFNVRG TNDDGHVANF VETEQVIYLD
     DCVSSFIQIR GSVPLFWEQP GLQVGSHRVR MSRGFEANAP AFDRHFRTLK DLYGKQIVVN
     LLGSKEGEHM LSKAFQSHLK ASEHASDIHM VSFDYHQMVK GGKAEKLHSV LKPQVQKFLD
     YGFFYFDGSA VQRCQSGTVR TNCLDCLDRT NSVQAFLGLE MLAKQLEALG LAEKPQLVTR
     FQEVFRSMWS VNGDSISKIY AGTGALEGKA KLKDGARSVT RTIQNNFFDS SKQEAIDVLL
     LGNTLNSDLA DKARALLTTG SLRVSEQTLQ SASSKVLKNM CENFYKYSKP KKIRVCVGTW
     NVNGGKQFRS IAFKNQTLTD WLLDAPKLAG IQEFQDKRSK PTDIFAIGFE EMVELNAGNI
     VNASTTNQKL WAVELQKTIS RDNKYVLLAS EQLVGVCLFV FIRPQHAPFI RDVAVDTVKT
     GMGGATGNKG AVAIRMLFHT TSLCFVCSHF AAGQSQVKER NEDFVEIARK LSFPMGRMLF
     SHDYVFWCGD FNYRIDLPNE EVKELIRQQN WDSLIAGDQL INQKNAGQIF RGFLEGKVTF
     APTYKYDLFS EDYDTSEKCR TPAWTDRVLW RRRKWPFDRS AEDLDLLNAS FQDESKILYT
     WTPGTLLHYG RAELKTSDHR PVVALIDIDI FEVEAEERQK IYKEVIAVQG PPDGTVLVSI
     KSSAQENTFF DDALIDELLQ QFAHFGEVIL IRFVEDKMWV TFLEGSSALN VLSLNGKELL
     NRTITITLKS PDWIKTLEEE MSLEKISVTL PSSTSSTLLG EDAEVSADFD MEGDVDDYSA
     EVEELLPQHL QPSSSSGLGT SPSSSPRTSP CQSPTAPEYS APSLPIRPSR APSRTPGPLS
     SQGAPVDTQP AAQKESSQTI EPKRPPPPRP VAPPARPAPP QRPPPPSGAR SPAPARKEFG
     GVGAPPSPGV TRREMEAPKS PGTARKDNIG RNQPSPQAGL AGPGPSGYGA ARPTIPARAG
     VISAPQSQAR VSAGRLTPES QSKPLETSKG PAVLPEPLKP QAAFPPQPSL PTPAQKLQDP
     LVPIAAPMPP SIPQSNLETP PLPPPRSRSS QSLPSDSSPQ LQQEQPTGQQ VKINGACGVK
     QEPTLKSDPF EDLSLSVLAV SKAQPSAQIS PVLTPDPKML IQLPSASQSK VNSLSSVSCM
     LTMPPVPEQS KSQESVGSSA NPFPSLPTRN PFTDRTAAPG NPFRVQSQES EATSWLSKEE
     PVSNSPFPPL MPLSHDMSKP SSSLDGFEDN FDLQSQSTVK TSNPKGWVTF DEDEDFPTKG
     KSRSVYPDSL GNTAASFDDD WSKGTNVSFC VLPARRPPPP PPPVPLLPPG TTSSAGPSTT
     LSSKASPTLD FTER
//
